Join us on February 3, 2026, for a Biorezo event dedicated to the talents driving innovation in immunology and oncology today.
Recognized experts will share their work, insights and the advances that are transforming our understanding of the immune system and cancer biology. They will discuss emerging approaches, new therapeutic strategies, and the levers that can accelerate research and innovation in these rapidly evolving fields.
This event fully reflects Eurobiomed’s ambition: to highlight the expertise shaping the future of immunology and oncology and to strengthen synergies across the health ecosystem.
Programme
5:00 – 5:30 pm | Welcome & registration
5:30 – 5:40 pm | Opening remarks
• Émilie Royère – General director of Eurobiomed
5:40 – 5:50 pm | Introduction
• Jaime Arengo – CEO of Adcytherix
5:50 – 6:50 pm | Company pitches and Q&A
• Kahimmune Therapeutics – Philippe Villain-Guillot
• Celsiege Biosciences – Sree Kant
• Orthos Therapeutics – Guillaume Dubreuil
• Massalia Therapeutics – Gary Brandam
6:50 – 7:05 pm | Closing remarks
• Pierre d’Epenoux – CEO of ImCheck Therapeutics
From 7:10 pm | Networking cocktail
Please note: this event is free and requires registration for members, partners, and innovative companies.
Venue: to be confirmed.
